Cuprina Holdings (Cayman) LTD
Cuprina Holdings (Cayman) LTD is a Cayman Islands holding company with its principal executive office in Singapore and investor relations support in Singapore and New York. Based on the industry classification, it operates in orthopedic, prosthetic, and surgical appliances and supplies, serving healthcare markets through a corporate structure centered outside the Cayman Islands.
Tilikausi 2025 · muutos edellisvuodesta
Kehitys 2022–2025
Liiketoiminta
Osuus liikevaihdostaBraces, supports, and related devices used to stabilize or aid the musculoskeletal system.
Artificial limbs and related replacement components for rehabilitation and mobility.
Consumable and support items used in surgical and procedural settings.
Activities related to marketing, distribution, and commercialization of medical products.
Asiakkaat
Cuprina’s customers are healthcare buyers that use orthopedic, prosthetic, and surgical products in clinical care and rehabilitation settings. These typically include hospitals, clinics, distributors, and specialist medical practitioners that purchase products for patient treatment and mobility support.
Buy surgical appliances and orthopedic supplies for procedures and inpatient care.
Buy prosthetic and orthopedic products used in outpatient treatment and recovery.
Buy in bulk for resale into regional healthcare channels and tenders.
Buy niche devices and consumables for patient-specific fitting and treatment.
Strategia
Cuprina’s strategic position appears centered on building a healthcare products business under an offshore holding-company structure with operating presence in Singapore. The key priorities are likely product commercialization, clinical adoption, and distribution reach across healthcare channels where regulatory credibility and supply reliability matter.
Device businesses depend on repeat usage and procurement relationships with healthcare buyers.
An offshore holding company with Singapore operations needs clear governance and execution across jurisdictions.
Maantiede
The company is incorporated in the Cayman Islands, with its principal executive office in Singapore, which suggests a cross-border operating and management footprint. Available filings also show investor relations support in Singapore and New York, indicating exposure to both Asian operating networks and U.S. capital markets.
Riskit
Cuprina faces the usual medical-device risks around regulation, product acceptance, and channel execution, because customers demand compliance, quality, and dependable supply. Cross-border operations also create exposure to jurisdictional complexity, including import rules, product approvals, and operational dependence on non-U.S. locations.
- Regulatory approval and compliance riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
Orthopedic and surgical products must meet health, safety, and import requirements before broad commercialization.
Kohdistuu: Product launches and market access
- Customer adoption riskVaikutus: KorkeaTodennäköisyys: Kohtalainen
Healthcare buyers require proven performance and clinician acceptance before switching suppliers.
Kohdistuu: Sales growth and recurring demand
- Cross-border operating complexityVaikutus: KeskitasoTodennäköisyys: Korkea
Cayman incorporation with Singapore operations can create tax, legal, and reporting complexity.
Kohdistuu: Corporate structure and compliance
Kirjanpito
Harkinnanvaraiset erätMedical products may be sold through distributors or direct channels with different timing for control transfer.
Vaikutus: Affects reported sales timing and quarterly comparability
Medical supplies and devices can require write-downs if demand is slow or products become obsolete.
Vaikutus: Affects gross profit and working capital
Principal operations and investor relations are outside the Cayman Islands and may involve multiple currencies.
Vaikutus: Affects reported equity and earnings volatility
Samankaltaisia listattuja yhtiöitä
Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.
Voyager Acquisition Corp./Cayman Islands
Biological Products, (No Diagnostic Substances)
Voyager Acquisition Corp.
Tungray Technologies Inc
TRSG · Construction, Mining & Materials Handling Machinery & Equip
Tungray Technologies Inc is a Cayman Islands-incorporated industrial company with operating activities and related-party counterparties in China and a…
Medtronic plc
MDT · Electromedical & Electrotherapeutic Apparatus
Medtronic plc designs, manufactures, and sells medical technologies used to diagnose, treat, and manage chronic and acute conditions across the body.
China Pharma Holdings, Inc
CPHI · Pharmaceutical Preparations
Leishen Energy Holding Co., Ltd.
LSE · Oil & Gas Field Machinery & Equipment
Cellyan Biotechnology Co., Ltd
HKPD · Wholesale-Drugs, Proprietaries & Druggists' Sundries
Cellyan Biotechnology Co., Ltd is a Cayman Islands holding company with operating subsidiaries in Hong Kong that serve the OTC pharmaceutical cross-border trade market.
Päivitetty: 28.9.2026